Riskpilot← Back to searchSign inGet full accessNåN Synaps AB
ABActiveOrg 5567927271Medical specialists activities · NACE 8622Est. 20091 employees
Revenue 2025
SEK 0
EBITDA margin
—
+82% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
SEK 7K
-99% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -10K | +82% |
| Net profit | SEK 7K | -99% |
| Total assets | SEK 4,4M | -5% |
| Equity | SEK 4,4M | -4% |
| Employees | 1 | — |
Legal name
NåN Synaps AB
Org number
5567927271
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
4 november 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Läkarverksamhet genom uthyrning av mig själv som läkare inom psykiatri i öppen och sluten vård samt konsultationer. Bedriva psykoterapeutisk verksamhet. Verksamheterna kan utgöras av egen praktik eller som delägare eller kompanjon i mottagning eller praktik. Utbildning och handledning inom verksamhetsområdena, samt personlig utveckling och start eller utveckling av verksamheter och team. Förvalta egen fastighet och egendom. Placering och förvaltning av ekonomiska tillgångar.
Address
Phone
+4626180921
Email
nilsake.sundin.nilsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 2 276 | 2 599 | 2 595 | 2 514 | 2 095 | 0 | 150 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | −96 | — |
| EBITDA | 1 135 | 1 280 | 745 | 1 016 | 1 375 | 1 381 | 1 095 | 879 | −359 | −57 | −10 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | −0 |
| EBIT | 1 135 | 1 280 | 745 | 1 016 | 1 375 | 1 381 | 1 095 | 879 | −359 | −57 | −10 |
| Net financials | 27 | 2 | 32 | 8 | 15 | — | 24 | 40 | 53 | 906 | 19 |
| Profit before tax | 1 161 | 1 282 | 777 | 985 | 1 588 | 1 589 | 1 119 | 919 | −105 | 849 | 9 |
| Tax | −264 | −291 | −182 | −225 | −350 | −347 | −236 | −192 | −0 | −12 | −2 |
| Net profit | 897 | 991 | 595 | 760 | 1 238 | 1 242 | 883 | 727 | −105 | 837 | 7 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 403 | 3 224 | 3 316 | 3 859 | 3 236 | 4 014 | 4 507 | 4 853 | 3 995 | 4 619 | 4 399 |
| Equity | 1 645 | 2 336 | 2 623 | 1 635 | 2 574 | 3 492 | 4 042 | 4 417 | 3 962 | 4 592 | 4 390 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 |
| Short-term debt | 190 | 320 | 125 | 1 617 | 254 | 322 | 265 | 236 | 32 | 27 | 9 |
| Total debt | 190 | 320 | 125 | 1 617 | 254 | 322 | 265 | 236 | 32 | 27 | 9 |
EBITDA margin
-1000000.0%
This company
15.8%
Market median
-6329214% vs market
20152025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20152025
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
20152025
Net profit margin
700000.0%
This company
8.1%
Market median
+8641875% vs market
20152025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JT Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NåN Synaps AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Thomas Holmgren | Audit | 0 companies |
| Mikael Nils-Åke Nilsson | Board of Directors | 0 companies |
| Anna Maria Nilsson | Deputy Board Member | 0 companies |